Find your path to Thomas
435 people in our graph share verified history with Thomas — schools, employers, funds. One of them is your warm intro.
Paul BragielunlockedThomas: together at University of Illinois Urbana-Champaign (1995–1997)
%20(1).png)
×3Thomas: together at Georgia Institute of Technology
×2Thomas: together at University of Illinois Urbana-Champaign
×5Thomas: together at DuPont
Executive at EpiVario
Intro paths
→
In turn, Thomas can intro founders to EpiVario's investors below.
EpiVario's investors · 1
Co-founders at EpiVario
SB
Shelley BergerCo-Founder
PM
Philipp MewsCo-Founder
Experience
- EpiVario, Inc.President and CEOcurrent2018 — presentPhiladelphia, Pennsylvania, United States
- ReEngage TherapeuticsPresident and CEOcurrent2024 — presentHouston, Texas, United States
- Georgia Institute of TechnologyAdvisory Boardcurrent2020 — presentAtlanta, Georgia, United States
- TANGO2 Research FoundationMember Board of Directorscurrent2023 — presentUnited States
- TremeBioCofounder and CEO2025 — 2026Atlanta, GA
- Pathway Consulting Group LtdPresident2017 — 2026Greater Philadelphia Area
- Inovio Pharmaceuticals Inc.General Counsel and Corporate Secretary2009 — 2017Blue Bell, PA
- Inovio Biomedical CorporationSenior Director Intellectual Property2009
- VGX PharmaceuticalsSenior Director Intellectual Property2007 — 2009
- DuPontSenior Counsel2005 — 2007
- Woodcock WashburnAttorney2004 — 2005
- Rosenbaum & AssociatesAssociate attorney2002 — 2004
- Marshall, Gerstein & Borun LLPAssociate attorney1999 — 2002
- PfizerLaw clerk1998 — 2000
Skills & more
Board LevelIntellectual PropertyPatentsPatent ProsecutionGovernment ProcurementLicensingPatent LitigationTrade SecretsPatentabilityArbitrationBiotechnologyBusiness Strategy
+12 more
Commercial LitigationContract NegotiationCorporate LawDue DiligenceLegal OpinionsLitigationPharmaceutical IndustryTrademarksStrategyLifesciencesRRegistered Patent AttorneyFrom Thomas's professional profile.
Frequently asked questions
- Who is Thomas Kim?
- Executive Officer, Director at EpiVario
- Where does Thomas Kim work?
- Thomas Kim is Executive at EpiVario.
- Where did Thomas Kim go to school?
- Thomas Kim studied at Washington University in St. Louis School of Law (JD, Law); University of Illinois Urbana-Champaign (MS, Biochemistry); Georgia Institute of Technology (BS, Chemistry).
Same school
Also attended Washington University in St. Louis School of Law26
Steve BrotmanManaging Partner, Founder at Alpha PartnersAkiko ShionoHead of Business Development at NordicNinjaJenny WittGeneral Counsel at Five Elms CapitalSandra M. MooreManaging Director & Chief Impact Officer at Advantage Capital PartnersJonathan GoldsteinManaging Director at Advantage Capital PartnersAmi GalaniCo-Founder & Partner at Tipt Ventures
+ 20 more
Also attended University of Illinois Urbana-Champaign864
Max LevchinCo-founder of PayPal; founder, chairman & CEO of Affirm; partner at SciFi VCLuke NosekCo-founder of PayPal; co-founder of GigafundSundeep PeechuGeneral Partner at Felicis VenturesDeep NisharInvestment Team at General CatalystPrashant ShahPartner at Monta Vista CapitalNoorPartner at Clear Ventures
+ 858 more
Also attended Georgia Institute of Technology707
Brando De CourtenData Engineer at P101 VenturesTom DyalCo-Founder at Redpoint VenturesWouter Van de PutteInvestment Director at Capricorn Venture PartnersWill McGinnisEntrepreneur and data science executive working at the intersection of AI/ML, technology, and business strategyJaya GuptaInvestor at Foundation CapitalJames WangGeneral Partner at Creative Ventures
+ 701 more
Shared employers
Also worked at EpiVario, Inc.1
Also worked at Inovio Pharmaceuticals Inc.2
Also worked at DuPont83
James MassaquoiSenior Investment Associate at Glasswing VenturesWilliam D. ProvinePresident & CEO at The Innovation SpaceNatalie EphraimProgram Manager – Mentorship & Partnerships at The Innovation SpaceTyler AmesEntrepreneur-In-Residence at The Innovation SpaceAlexander KhutorskyVice President, Mergers & Acquisitions at DuPont at The Innovation SpaceAlbert J. RobichaudPartner at Cure Ventures
+ 77 more